Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. - Wikidata - wikimedia - TriplyDB

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

http://www.wikidata.org/entity/Q48589259

about

Nanoparticles for brain drug delivery Protein nanoparticles as drug delivery carriers for cancer therapy Combinatorial approaches for the identification of brain drug delivery targets.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for Gliomas.Blood-brain barrier transport of therapeutics via receptor-mediation Endocytic mechanisms for targeted drug delivery Polymeric nanoparticles for the drug delivery to the central nervous system.Targeting anti-HIV drugs to the CNS.Layered double hydroxide nanoparticles in gene and drug delivery.Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting.Receptor-mediated therapeutic transport across the blood-brain barrier.In vivo methods to study uptake of nanoparticles into the brain.Potential of polymeric nanoparticles in AIDS treatment and prevention.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.A translational approach to congenital non-obstructive hydronephrosis.Biopolymer nanoparticle production for controlled release of biopharmaceuticals.Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.Developing therapeutic antibodies for neurodegenerative disease.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.The blood-brain barrier: structure, function and therapeutic approaches to cross it.A sight on protein-based nanoparticles as drug/gene delivery systems.Biomaterials for Enhancing CNS Repair.Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity.Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents.In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Polymeric nanospheres modified with YIGSR peptide for tumor targeting.Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.Citrate-stabilized lanthanide-doped nanoparticles: brain penetration and interaction with immune cells and neurons.Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kinetics.

P2860

Q21285117-22CF637F-9B1D-4E18-BE11-34B8AAB88714 Q23923552-90EB45F5-EABA-47BE-957C-31CE6453B13B Q31119779-544AC040-5192-4893-B99A-A28C2BC865A5 Q34030709-5C817836-039C-4FE5-9A0B-0DB980E5F1D3 Q35021768-DE31184D-2C20-4FE0-BB8B-79E69C8AAFF6 Q36020442-E36A8E9D-B89F-4D4C-962D-DA586DCCA6F6 Q36874295-8A0A82AC-8849-4862-9411-D302D7B4334D Q36894849-9066B74B-2EEF-4B3E-8968-A64AFB6C8C60 Q37076360-F1F75662-63FF-40D9-8922-71DF28449BD9 Q37368323-A7D0C8D8-63E5-4777-8891-D480A5944864 Q37580918-CB823EFC-1796-4B65-BBE5-05F7E1CE5E5D Q37698620-E4C68EB0-EA2F-46E6-B174-412F90C6DFCF Q37772516-6D1F15A4-8973-4003-9DDC-4CE63F99A4C4 Q37773246-04835DE5-3FD0-400D-904A-DE41E4D5356B Q37798178-207697FB-024F-4C4D-87FF-92169003AD56 Q37818325-26FB24E8-EF43-4F47-8FD0-3CF4F3A55D89 Q37995554-1EF5C7EC-FB9A-401B-9E8C-02EAAEA087A9 Q38007992-C5F04D26-7918-487A-8830-09FCC944077A Q38050962-EE4A7442-C704-4DAE-874A-F2AFFAC397FE Q38072083-016C4D26-E9CA-4544-A38C-6FBF981EA30E Q38075010-A06735A2-7EB6-47EC-AFD2-CF91E86F811F Q38095360-C51638CD-5AF3-4965-BEC9-48BC0BE08475 Q38177370-556FF082-FCB6-4733-AB22-2686EFF52F03 Q38232202-113EFFC5-E709-443E-AD41-3D56FA04E504 Q38573478-FB3651EB-227C-4A9F-B7EE-9A73F4C54665 Q38850744-AB996953-067E-4E3E-BFCA-37F6E2FE14E4 Q38996889-90C5EB72-E6C8-41EC-8BC7-688147ACA183 Q39004638-4B6BDB40-00AD-4B95-842A-D0B563581E2B Q39438422-859D9F6B-5FCA-4E11-B219-4E702D43E450 Q39703349-644075B2-EF23-4FDD-85E3-7C72E0804749 Q39739004-9FFB845F-89BF-4BCA-98F0-294E7C7F18C2 Q40060003-B170CCB6-A5D8-49AB-8A92-7B2BC90C07E7 Q43013090-F97C51E5-56B1-4F11-B2CC-DD11CA405201 Q45968864-A51A6366-93A3-42DF-985B-55FABD0FF872 Q47838302-5704BE0B-CD9A-478A-8924-0BC7F487D6A2 Q48169419-B5107FC4-44A4-4BD5-A313-5B2AC53E0C5B Q48284053-AA6311AD-922D-44AD-8565-CF3C2C700A5F Q48441967-875BBBCA-242E-475F-9916-C8574C89F7CC Q51653581-34A7A6EC-AE88-426F-AF24-8D73AB3A9435

P2860

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

http://www.wikidata.org/entity/Q48589259

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@en

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@nl

type

label

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@en

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@nl

prefLabel

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@en

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@nl

P1433

Q48589259-3F5AD293-11A8-4278-BB7B-CA5FBF035EAB

P1476

Q48589259-0BDFF7BD-8FA8-45C6-9D25-D36FE0BE1F9A

P2093

Q48589259-098EFC84-E105-4865-859D-8FBD4C7EE6A4

Q48589259-0E39F546-B012-4896-AC7B-F8A86FFEF09C

Q48589259-13E57372-2231-4E4C-9C14-DF8CEDACF69A

Q48589259-365CCFF2-0F61-4067-AA6D-5056279AC734

Q48589259-3C99717D-C163-4ABD-B74E-1F228D4D3346

Q48589259-DB3D2145-7C83-48C6-A026-88AFE8E26AED

Q48589259-FD069903-6A2A-492B-9CE5-4D94C178A23B

P2860

Q48589259-0E3B7713-8E38-4883-A4A4-9E19480061C3

Q48589259-1000ABEC-A22B-4C2B-BAF1-08C39A6FEF47

Q48589259-10438B0C-529C-4CCC-81E2-B17E008AD691

Q48589259-13140552-0C6F-4852-84A1-AD8A16108F66

Q48589259-1CD4C9AF-38F9-433C-BD26-1A19F623C195

Q48589259-1D7A3907-5E3A-46B7-B7F5-407C2E513F6B

Q48589259-3F14AE7C-E134-4478-B771-507437D328A4

Q48589259-54678B0D-1BBA-4D32-893C-4E27BC663918

Q48589259-74C80BBE-0913-447E-8EC8-067D16377B89

Q48589259-7AA6665D-F176-4451-B508-D19FE61DEB29

P304

Q48589259-73528468-E1F4-4553-9AD0-32C08102822A

P31

Q48589259-EE0CA527-C339-4A4D-B957-BE62D45BF332

P356

Q48589259-B3B1F3CA-3CD7-4941-89AE-1CB41E6501A9

P433

Q48589259-F1E4EAB1-FDE3-4692-AA53-7A2F8A8EE220

P478

Q48589259-3D91A395-D9F1-4202-808C-96CBBFF2FA9E

P577

Q48589259-4C0C64A9-0F4C-4043-B451-8539F6E9A26D

P5875

Q48589259-EBC969AC-8422-45A3-889F-D486F789A11E

P698

Q48589259-0642351D-B78C-46C4-A2D6-2414B8D46E22

P921

Q48589259-9CA7F5F8-C1B8-453E-9AF6-ACAD9F138D52

P356

10611860600612953

P1433

Journal of Drug Targeting

P1476

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

@en

P2093

Amit Rawat

http://www.w3.org/2001/XMLSchema#string

Kapil Khatri

http://www.w3.org/2001/XMLSchema#string

Praveen Dubey

http://www.w3.org/2001/XMLSchema#string

Prem N Gupta

http://www.w3.org/2001/XMLSchema#string

Sunil Mahor

http://www.w3.org/2001/XMLSchema#string

Suresh P Vyas

http://www.w3.org/2001/XMLSchema#string

Vivek Mishra

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

Receptor-mediated transcytosis of transferrin across the blood-brain barrier

Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro.

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.

The blood-brain barrier. Transport across the cerebral endothelium.

Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Prospects for immunotoxin therapy in cancer.

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.

Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Human blood-brain barrier transferrin receptor.

P304

45-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10611860600612953

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7177287

http://www.w3.org/2001/XMLSchema#string

P698

16603451

http://www.w3.org/2001/XMLSchema#string

P921